Switch to
More onapp

How to use scorecard? Learn more

IND Swift Laboratories Ltd

INDSWFTLAB
Health CarePharmaceuticals
SmallcapWith a market cap of ₹714 cr, stock is ranked 1,502
High RiskStock is 5.70x as volatile as Nifty
116.554.30 (-3.56%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Avg

Price return has been average, nothing exciting

Valuation

Avg

Can be considered moderately valued vs the market

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Good

The stock is underpriced and is not in the overbought zone

Red flags

Avg

The stock has a moderate number of red flags

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹714 cr, stock is ranked 1,502
High RiskStock is 5.70x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
16.54
PB RatioPB Ratio
1.05
Dividend YieldDiv. Yield
Sector PESector PE
51.76
Sector PBSector PB
5.90
Sector Div YldSctr Div Yld
0.56%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Ind-Swift Laboratories Limited is a company focused on the development of active pharmaceutical ingredients (APIs).

Financial TrendFinancial statements 

20202021202220230.810.911.081.24-0.02-0.00-0.000.05
Revenue
Profit
Loss
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

High Pledged Promoter Holding
Lower pledged promoter holdings is considered better

A significant proportion of promoter holdings is pledged

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Agreements,Contracts,Arrangements,MOU-XBRL 
Announced OnMar 30, 2024

IND-SWIFT LABORATORIES LIMITED has informed the Exchange regarding Loan facility agreement | Download

IND-SWIFT LABORATORIES LIMITED has informed the Exchange regarding Loan facility agreement | Download

Outcome of Board Meeting 
Announced OnMar 30, 2024

Ind-Swift Laboratories Limited has informed the Exchange regarding Board meeting held on March 30, 2024. | Download

Ind-Swift Laboratories Limited has informed the Exchange regarding Board meeting held on March 30, 2024. | Download

Cash Dividend 
Ex. DateSep 20, 2011

Final • Div/Share: ₹ 1

See all events